- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 27
  num_fold: 4093
  S: 3167
  I: 742
  R: 184
  median_fold: 2.0
  percent: 3.2
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 24
  num_fold: 1273
  S: 891
  I: 346
  R: 36
  median_fold: 3.0
  percent: 0.99
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 182
  num_fold: 22186
  S: 15373
  I: 5021
  R: 1792
  median_fold: 2.9
  percent: 17.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 48
  num_fold: 3334
  S: 2158
  I: 1061
  R: 115
  median_fold: 3.2
  percent: 2.6
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 79
  num_fold: 7099
  S: 3923
  I: 2617
  R: 559
  median_fold: 4.2
  percent: 5.5
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 17
  num_fold: 1327
  S: 956
  I: 298
  R: 73
  median_fold: 2.5
  percent: 1.0
  priority: 1
- vaccine: BNT162b2
  dosage: 4.0
  infection: ''
  num_ref_name: 3
  num_fold: 198
  S: 2
  I: 68
  R: 128
  median_fold: 40.0
  percent: 0.15
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.12
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.011
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 68
  num_fold: 9298
  S: 6211
  I: 2538
  R: 549
  median_fold: 3.9
  percent: 7.2
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 9
  num_fold: 393
  S: 268
  I: 101
  R: 24
  median_fold: 3.1
  percent: 0.31
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 22
  num_fold: 4473
  S: 2960
  I: 1437
  R: 76
  median_fold: 4.3
  percent: 3.5
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 445
  S: 226
  I: 215
  R: 4
  median_fold: 3.0
  percent: 0.35
  priority: 2
- vaccine: mRNA-1273
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 526
  S: 260
  I: 263
  R: 3
  median_fold: 12.0
  percent: 0.41
  priority: 2
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 22
  num_fold: 1510
  S: 1079
  I: 363
  R: 68
  median_fold: 2.9
  percent: 1.2
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 8
  num_fold: 198
  S: 141
  I: 48
  R: 9
  median_fold: 2.6
  percent: 0.15
  priority: 3
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 558
  S: 289
  I: 253
  R: 16
  median_fold: 4.6
  percent: 0.43
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 10
  num_fold: 1752
  S: 689
  I: 559
  R: 504
  median_fold: 6.0
  percent: 1.4
  priority: 4
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 4
  num_fold: 680
  S: 587
  I: 93
  R: 0
  median_fold: 3.3
  percent: 0.53
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 40
  num_fold: 3599
  S: 1953
  I: 1044
  R: 602
  median_fold: 4.4
  percent: 2.8
  priority: 4
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 14
  num_fold: 1847
  S: 1212
  I: 519
  R: 116
  median_fold: 3.6
  percent: 1.4
  priority: 4
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 799
  S: 266
  I: 533
  R: 0
  median_fold: 6.8
  percent: 0.62
  priority: 4
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 11
  num_fold: 2692
  S: 1504
  I: 853
  R: 335
  median_fold: 4.2
  percent: 2.1
  priority: 6
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 609
  S: 170
  I: 438
  R: 1
  median_fold: 9.4
  percent: 0.47
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.37
  priority: 7
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.13
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.1
  priority: 8
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 390
  S: 242
  I: 148
  R: 0
  median_fold: 3.3
  percent: 0.3
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 19
  num_fold: 2050
  S: 1440
  I: 590
  R: 20
  median_fold: 2.8
  percent: 1.6
  priority: 8
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.19
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 14
  num_fold: 4306
  S: 762
  I: 2704
  R: 840
  median_fold: 12.0
  percent: 3.4
  priority: 8
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 5
  num_fold: 10528
  S: 2303
  I: 5176
  R: 3049
  median_fold: 14.0
  percent: 8.2
  priority: 8
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 275
  S: 110
  I: 103
  R: 62
  median_fold: 8.1
  percent: 0.21
  priority: 9
- vaccine: NVX-CoV2373
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 212
  S: 48
  I: 164
  R: 0
  median_fold: 8.2
  percent: 0.17
  priority: 9
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 611
  S: 172
  I: 399
  R: 40
  median_fold: 8.1
  percent: 0.48
  priority: 10
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 4882
  S: 4850
  I: 32
  R: 0
  median_fold: 2.3
  percent: 3.8
  priority: 24
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 423
  S: 170
  I: 250
  R: 3
  median_fold: 7.4
  percent: 0.33
  priority: 34
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 284
  S: 242
  I: 34
  R: 8
  median_fold: 2.6
  percent: 0.22
  priority: 34
- vaccine: mRNA-monovalent
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 532
  S: 320
  I: 67
  R: 145
  median_fold: 3.0
  percent: 0.41
  priority: 47
- vaccine: mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 260
  S: 120
  I: 70
  R: 70
  median_fold: 7.6
  percent: 0.2
  priority: 47
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 70
  I: 133
  R: 67
  median_fold: 7.7
  percent: 0.21
  priority: 48
- vaccine: mRNA-bivalent + mRNA-monovalent
  dosage: 4.0
  infection: infected
  num_ref_name: 2
  num_fold: 138
  S: 18
  I: 64
  R: 56
  median_fold: 17.0
  percent: 0.11
  priority: 48
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.17
  priority: 50
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 592
  S: 408
  I: 142
  R: 42
  median_fold: 4.0
  percent: 0.46
  priority: 52
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 104
  S: 28
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.081
  priority: 54
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.2
  priority: 56
- vaccine: CoronaVac or BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 588
  S: 541
  I: 47
  R: 0
  median_fold: 4.2
  percent: 0.46
  priority: 57
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 225
  S: 98
  I: 107
  R: 20
  median_fold: 7.5
  percent: 0.18
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0047
  priority: 64
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 552
  S: 425
  I: 127
  R: 0
  median_fold: 2.6
  percent: 0.43
  priority: 64
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.21
  priority: 65
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 12
  num_fold: 1792
  S: 511
  I: 457
  R: 824
  median_fold: 12.0
  percent: 1.4
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 12
  S: 6
  I: 5
  R: 1
  median_fold: 4.9
  percent: 0.0093
  priority: 68
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 1187
  S: 459
  I: 482
  R: 246
  median_fold: 7.9
  percent: 0.92
  priority: 68
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.069
  priority: 69
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.16
  priority: 70
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.14
  priority: 73
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.53
  priority: 73
- vaccine: BBIBP-CorV + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 149
  S: 113
  I: 36
  R: 0
  median_fold: 3.5
  percent: 0.12
  priority: 76
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 252
  S: 52
  I: 182
  R: 18
  median_fold: 7.8
  percent: 0.2
  priority: 78
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 649
  S: 372
  I: 271
  R: 6
  median_fold: 4.7
  percent: 0.51
  priority: 79
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 92
  S: 68
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.072
  priority: 79
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 528
  S: 320
  I: 177
  R: 31
  median_fold: 3.2
  percent: 0.41
  priority: 92
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 11
  num_fold: 1214
  S: 889
  I: 264
  R: 61
  median_fold: 3.0
  percent: 0.95
  priority: 92
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 78
  S: 32
  I: 43
  R: 3
  median_fold: 7.2
  percent: 0.061
  priority: 92
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 9
  num_fold: 929
  S: 574
  I: 308
  R: 47
  median_fold: 3.5
  percent: 0.72
  priority: 92
